The professional's guide to product selection
Bactroban contains mupirocin, an antibiotic. It has bacteriostatic properties at minimum inhibitory concentrations and bactericidal properties at the higher concentrations reached when applied locally
A liquid bath additive containing 82.95% w/w soya oil and 15% w/w lauromacrogols.
A cream containing 5% w/w urea and 3% w/w lauromacrogols.
Quick drying, non-greasy, medical silicone gel enriched with vitamin E. Produces an invisible matt finish, making it especially suitable for use on the face or under cosmetic camouflage. Can be applied in a single movement. Dries within seconds of application. Also available with SPF 40 UV protection.
A standard (1.2mm thick) transparent, self-adhesive silicone dressing. Can be applied under clothing and compression therapy. Each dressing is designed to be washed and reused for several weeks
Ultra-thin (0.3mm), flexible, self-adhesive thin and transparent medical silicone dressing. Each dressing can be worn continuously for up to 7 days then discarded and replaced
Baricitinib is a selective and reversible inhibitor of Janus kinase (JAK)1 and JAK2. In isolated enzyme assays, baricitinib inhibited the activities of JAK1, JAK2, Tyrosine Kinase 2 and JAK3 with IC50 values of 5.9, 5.7, 53 and > 400 nM, respectively. Janus kinases (JAKs) are enzymes that transduce intracellular signals from cell surface receptors for a number of cytokines and growth factors involved in haematopoiesis, inflammation and immune function. Within the intracellular signalling pathway, JAKs phosphorylate and activate signal transducers and activators of transcription (STATs), which activate gene expression within the cell. Baricitinib modulates these signalling pathways by partially inhibiting JAK1 and JAK2 enzymatic activity, thereby reducing the phosphorylation and activation of STATs.
Moisturising emollient ointment containing 50% w/w liquid paraffin BP and 50% w/w white soft paraffin.